Neil Desai, M.D.
Director of Clinical Research, Radiation Oncology
Associate Professor
Endowed Title Dedman Family Scholar in Clinical Care
Department Radiation Oncology
You have reached the Academic Profile.
For more information on the doctor and patient care, please visit the clinical profile.
View Clinical Profile
Education
- Medical School
- Yale University School of Medicine (2010)
- Internship
- Memorial Sloan-Kettering Cancer Center (2011), Transitional Year
- Residency
- Memorial Sloan Kettering Cancer Center (2015), Radiation Oncology
Research Interest
- Bladder cancer
- Prostate cancer
Publications
Featured Publications
- Enrichment of "Cribriform" morphologies (intraductal and cribriform adenocarcinoma) and genomic alterations in radiorecurrent prostate cancer.
- Shah RB, Palsgrove DN, Desai NB, Gagan J, Mennie A, Raj G, Hannan R, Mod Pathol 2022 May
- Primary central nervous system lymphoma: a real-world comparison of therapy access and outcomes by hospital setting.
- Patel AM, Ali O, Kainthla R, Rizvi SM, Awan FT, Patel T, Pan E, Maher E, Desai NB, Timmerman R, Kumar KA, Ramakrishnan Geethakumari P, Neurooncol Pract 2022 May 9 3 183-192
- Dose-Intensified Stereotactic Ablative Radiation for Localized Prostate Cancer.
- Chen L, Gannavarapu BS, Desai NB, Folkert MR, Dohopolski M, Gao A, Ahn C, Cadeddu J, Bagrodia A, Woldu S, Raj GV, Roehrborn C, Lotan Y, Timmerman RD, Garant A, Hannan R, Front Oncol 2022 12 779182
- Volumetric Modulated Arc Therapy Enabled Total Body Irradiation (VMAT-TBI): Six-year Clinical Experience and Treatment Outcomes.
- Zhang-Velten ER, Parsons D, Lee P, Chambers E, Abdulrahman R, Desai NB, Dan T, Wardak Z, Timmerman R, Vusirikala M, Patel P, Simms-Waldrip T, Aquino V, Koh A, Tan J, Iqbal Z, Zhang Y, Reynolds R, Chiu T, Joo M, Hrycushko B, Ouyang L, Lamphier R, Yan Y, Jiang SB, Kumar KA, Gu X, Transplant Cell Ther 2021 Nov
- Stereotactic Ablative Radiotherapy for High-Risk Prostate Cancer-a Prospective Multi-level MRI-based Dose Escalation Trial.
- Hannan R, Salamekh S, Desai NB, Garant A, Folkert MR, Costa DN, Mannala S, Ahn C, Mohamad O, Laine A, Kim DWN, Dickinson T, Raj GV, Shah RB, Wang J, Jia X, Choy H, Roehrborn CG, Lotan Y, TimmermanMD RD, Int J Radiat Oncol Biol Phys 2021 Nov
- PSA-Net: Deep learning-based physician style-aware segmentation network for postoperative prostate cancer clinical target volumes.
- Balagopal A, Morgan H, Dohopolski M, Timmerman R, Shan J, Heitjan DF, Liu W, Nguyen D, Hannan R, Garant A, Desai N, Jiang S, Artif Intell Med 2021 11 121 102195
- Stereotactic Ablative Radiation Therapy for Oligoprogressive Renal Cell Carcinoma.
- Schoenhals JE, Mohamad O, Christie A, Zhang Y, Li D, Singla N, Bowman I, Arafat W, Hammers H, Courtney K, Cole S, Bagrodia A, Margulis V, Desai N, Garant A, Choy H, Timmerman R, Brugarolas J, Hannan R, Adv Radiat Oncol 2021 Sep-Oct 6 5 100692
- Cachexia is Prevalent in Patients with Hepatocellular Carcinoma and Associated with Worse Prognosis.
- Rich NE, Phen S, Desai N, Mittal S, Yopp AC, Yang JD, Marrero JA, Iyengar P, Infante RE, Singal AG, Clin Gastroenterol Hepatol 2021 Sep
- Hydrogel Spacer Rectal Wall Infiltration Associated With Severe Rectal Injury and Related Complications After Dose Intensified Prostate Cancer Stereotactic Ablative Radiation Therapy.
- McLaughlin MF, Folkert MR, Timmerman RD, Hannan R, Garant A, Hudak SJ, Costa DN, Desai NB, Adv Radiat Oncol 2021 Jul-Aug 6 4 100713
- Metastasis-directed radiation therapy after radical cystectomy for bladder cancer.
- Miranda AF, Howard JM, McLaughlin M, Meng X, Clinton T, Sanli Ö, Garant A, Bagrodia A, Margulis V, Lotan Y, Hannan R, Desai N, Woldu SL, Urol Oncol 2021 Jun